Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000386475

Medchemexpress LLC Clarithromycin | 81103-11-9 | 99.93% | 747.95 | 500 MG
SDP

Catalog No. 5000386475
Encompass_Preferred

Clarithromycin has a broad spectrum of antimicrobial activity. It inhibits CYP3A4-catalyzed triazolam alpha-hydroxylation with an IC50 (Ki) value of 56 (43) μM. It significantly inhibits the hERG potassium current and affects autophagic flux by impairing the signaling pathway linking hERG1 and PI3K. It has also shown activity against Mycobacterium avium complex infection in mice.

  • Broad spectrum of antimicrobial activity
  • Inhibits CYP3A4-catalyzed triazolam alpha-hydroxylation
  • Significantly inhibits hERG potassium current
  • Affects autophagic flux by impairing the signaling pathway linking hERG1 and PI3K
  • Induces intracytoplasmic vacuoles in various cell lines
  • Triggers apoptotic cell death in colorectal cancer cells
  • Increases LC3-II/LC3-I ratio dose- and time-dependently
  • Reduced organ cell counts in animal models of Mycobacterium avium infection

Catalog No. 50-003-86475 Supplier Medchemexpress LLC Supplier No. HY17508500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Clarithromycin has a broad spectrum of antimicrobial activity. It inhibits CYP3A4-catalyzed triazolam alpha-hydroxylation with an IC50 (Ki) value of 56 (43) μM. It significantly inhibits the hERG potassium current and affects autophagic flux by impairing the signaling pathway linking hERG1 and PI3K. It has also shown activity against Mycobacterium avium complex infection in mice.

  • Broad spectrum of antimicrobial activity
  • Inhibits CYP3A4-catalyzed triazolam alpha-hydroxylation
  • Significantly inhibits hERG potassium current
  • Affects autophagic flux by impairing the signaling pathway linking hERG1 and PI3K
  • Induces intracytoplasmic vacuoles in various cell lines
  • Triggers apoptotic cell death in colorectal cancer cells
  • Increases LC3-II/LC3-I ratio dose- and time-dependently
  • Reduced organ cell counts in animal models of Mycobacterium avium infection

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.